logo
Select company
Select metric
$ -19.67EBITDA per Share
VS
Market
1
Sector
3
Industry
3
History
100
$ 2.58Close
$ 2.36 - $ 27 52-Week Range
Ticker Information

Ticker

AIM

Company Name

AIM IMMUNOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

AIM IMMUNOTECH INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AIM - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -14.93M$ -19.671759.29K
3/31/2025$ -13.89M$ -19.751703.3K
12/31/2024$ -16.18M$ -28.891560.17K
9/30/2024$ -23.1M$ -40.051576.77K
6/30/2024$ -27.28M$ -51.621528.38K
3/31/2024$ -30.58M$ -61.821494.58K
12/31/2023$ -28.44M$ -58.531485.85K
9/30/2023$ -20.27M$ -41.691486.35K
6/30/2023$ -19.02M$ -39.291484.11K
3/31/2023$ -19.01M$ -39.281484K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AIM IMMUNOTECH INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -26.83.
  • Over the past 5 years, AIM IMMUNOTECH INC's average EBITDAPS has been $ -38.1.
  • The median EBITDAPS for AIM IMMUNOTECH INC during this period was $ -39.2
  • AIM IMMUNOTECH INC reached its highest EBITDAPS over the past 5 years at $ -19.67.
  • The lowest EBITDAPS recorded by AIM IMMUNOTECH INC in the same timeframe $ -61.82

AIM IMMUNOTECH INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
SILO : SILO PHARMA INC $ -0.78VIVS : VIVOSIM LABS INC $ -0.47HCWB : HCW BIOLOGICS INC $ -5.01CDIO : CARDIO DIAGNOSTICS HOLDINGS INC $ -3.37IBO : IMPACT BIOMEDICAL INC $ -2.97PMCB : PHARMACYTE BIOTECH INC $ -0.17APVO : APTEVO THERAPEUTICS INC $ -32.19ACXP : ACURX PHARMACEUTICALS INC $ -8.4PALI : PALISADE BIO INC $ -2.44GNPX : GENPREX INC $ -0.63

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for AIM IMMUNOTECH INC is calculated as follows: EBITDA [ $ -10.44M ] / (Shares WA [ 389.07K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -26.83 ]

AIM - EBITDA per Share, Last 5 years

$ -61.82

Minimum

Mar 31, 2024

$ -19.67

Maximum

Jun 30, 2025

$ -38.1

Average

$ -39.2

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28